These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7952498)
1. Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas. Tanaka Y; Abe Y; Tsugu A; Takamiya Y; Akatsuka A; Tsuruo T; Yamazaki H; Ueyama Y; Sato O; Tamaoki N Virchows Arch; 1994; 425(2):133-8. PubMed ID: 7952498 [TBL] [Abstract][Full Text] [Related]
2. Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts. Takamiya Y; Abe Y; Tanaka Y; Tsugu A; Kazuno M; Oshika Y; Maruo K; Ohnishi Y; Sato O; Yamazaki H; Kijima H; Ueyama Y; Tamaoki N; Nakamura M Br J Cancer; 1997; 76(4):445-50. PubMed ID: 9275020 [TBL] [Abstract][Full Text] [Related]
3. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer. Hegewisch-Becker S; Staib F; Löning T; Pichlmeier U; Kröger N; Reymann A; Hossfeld DK Ann Oncol; 1998 Jan; 9(1):85-93. PubMed ID: 9541688 [TBL] [Abstract][Full Text] [Related]
4. Determining MDR1/P-glycoprotein expression in breast cancer. Faneyte IF; Kristel PM; van de Vijver MJ Int J Cancer; 2001 Jul; 93(1):114-22. PubMed ID: 11391630 [TBL] [Abstract][Full Text] [Related]
5. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Tóth K; Vaughan MM; Peress NS; Slocum HK; Rustum YM Am J Pathol; 1996 Sep; 149(3):853-8. PubMed ID: 8780389 [TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human. Melaine N; Liénard MO; Dorval I; Le Goascogne C; Lejeune H; Jégou B Biol Reprod; 2002 Dec; 67(6):1699-707. PubMed ID: 12444043 [TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Abe Y; Ohnishi Y; Yoshimura M; Ota E; Ozeki Y; Oshika Y; Tokunaga T; Yamazaki H; Ueyema Y; Ogata T; Tamaoki N; Nakamura M Br J Cancer; 1996 Dec; 74(12):1929-34. PubMed ID: 8980392 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo. Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis. Suwa H; Ohshio G; Arao S; Imamura T; Yamaki K; Manabe T; Imamura M; Hiai H; Fukumoto M Jpn J Cancer Res; 1996 Jun; 87(6):641-9. PubMed ID: 8766529 [TBL] [Abstract][Full Text] [Related]
10. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Cooray HC; Blackmore CG; Maskell L; Barrand MA Neuroreport; 2002 Nov; 13(16):2059-63. PubMed ID: 12438926 [TBL] [Abstract][Full Text] [Related]
11. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810 [TBL] [Abstract][Full Text] [Related]
12. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1. Wang N; Zhang Q; Ning B; Luo L; Fang Y Biomed Pharmacother; 2017 Jun; 90():368-374. PubMed ID: 28380412 [TBL] [Abstract][Full Text] [Related]
13. A T3587G germ-line mutation of the MDR1 gene encodes a nonfunctional P-glycoprotein. Mutoh K; Mitsuhashi J; Kimura Y; Tsukahara S; Ishikawa E; Sai K; Ozawa S; Sawada J; Ueda K; Katayama K; Sugimoto Y Mol Cancer Ther; 2006 Apr; 5(4):877-84. PubMed ID: 16648557 [TBL] [Abstract][Full Text] [Related]
15. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Zhou SF Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431 [TBL] [Abstract][Full Text] [Related]
16. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma? Ashmore SM; Thomas DG; Darling JL Anticancer Drugs; 1999 Nov; 10(10):861-72. PubMed ID: 10630353 [TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein of blood brain barrier: cross-reactivity of Mab C219 with a 190 kDa protein in bovine and rat isolated brain capillaries. Beaulieu E; Demeule M; Pouliot JF; Averill-Bates DA; Murphy GF; Béliveau R Biochim Biophys Acta; 1995 Jan; 1233(1):27-32. PubMed ID: 7833346 [TBL] [Abstract][Full Text] [Related]
18. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042 [TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells. Wang X; Ji C; Ma D; Zhao J; Hou M; Yu H; Zang S Leuk Lymphoma; 2007 Aug; 48(8):1600-9. PubMed ID: 17701592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]